Amendment NC87 to Health Bill
United Kingdom · UK Parliament · 7 September 2026
The world's political record
Person
United Kingdom · Official source
27 October 2026 · United Kingdom · House of Commons
21 October 2026 · United Kingdom · House of Commons
21 October 2026 · United Kingdom · House of Commons
21 October 2026 · United Kingdom · House of Commons
21 October 2026 · United Kingdom · House of Commons
20 October 2026 · United Kingdom · UK Parliament
20 October 2026 · United Kingdom · UK Parliament
20 October 2026 · United Kingdom · UK Parliament
20 October 2026 · United Kingdom · UK Parliament
20 October 2026 · United Kingdom · House of Commons
19 October 2026 · United Kingdom · UK Parliament
19 October 2026 · United Kingdom · UK Parliament
19 October 2026 · United Kingdom · UK Parliament
19 October 2026 · United Kingdom · UK Parliament
19 October 2026 · United Kingdom · UK Parliament
19 October 2026 · United Kingdom · UK Parliament
16 October 2026 · United Kingdom · House of Commons
16 October 2026 · United Kingdom · House of Commons
15 October 2026 · United Kingdom · UK Parliament
14 October 2026 · United Kingdom · House of Commons
14 October 2026 · United Kingdom · House of Commons
14 October 2026 · United Kingdom · House of Commons
14 October 2026 · United Kingdom · House of Commons
14 October 2026 · United Kingdom · House of Commons
Showing the 24 most recent votes of 261. Browse the full list
United Kingdom · UK Parliament · 7 September 2026
United Kingdom · UK Parliament · 7 September 2026
United Kingdom · UK Parliament · 7 September 2026
United Kingdom · UK Parliament · 7 September 2026
United Kingdom · UK Parliament · 7 September 2026
United Kingdom · UK Parliament · 4 September 2026
To ask the Secretary of State for Health and Social Care, whether she has asked NICE to review the position of nabiximols in the treatment pathway for MS-related spasticity, including its use earlier in the pathway.
United Kingdom · UK Parliament · 4 September 2026
To ask the Secretary of State for Health and Social Care, how many patients with multiple sclerosis were prescribed nabiximols on the NHS in England in each of the last three years by integrated care board.
United Kingdom · UK Parliament · 4 September 2026
To ask the Secretary of State for Health and Social Care, what assessment her Department has made of trends in the level of regional variation in access to nabiximols for MS-related spasticity since NICE guideline NG144 was published.
United Kingdom · UK Parliament · 4 September 2026
To ask the Secretary of State for Health and Social Care, what steps she is taking to ensure integrated care boards commission nabiximols in line with NICE guideline NG144.
United Kingdom · UK Parliament · 2 September 2026
United Kingdom · UK Parliament · 2 September 2026
United Kingdom · UK Parliament · 14 July 2026
United Kingdom · UK Parliament · 25 March 2026
United Kingdom · UK Parliament · 25 March 2026
United Kingdom · UK Parliament · 25 March 2026
United Kingdom · UK Parliament · 25 March 2026
United Kingdom · UK Parliament · 25 March 2026
United Kingdom · UK Parliament · 25 March 2026
United Kingdom · UK Parliament · 25 March 2026
United Kingdom · UK Parliament · 25 March 2026
United Kingdom · UK Parliament · 25 March 2026
United Kingdom · UK Parliament · 25 March 2026
United Kingdom · UK Parliament · 25 March 2026
United Kingdom · UK Parliament · 25 March 2026
Showing the 24 most recent records of 51. Browse the full list